The Wayback Machine - https://web.archive.org/web/20120223234245/https://en.wikipedia.org/wiki/SEP-227,162

SEP-227,162

From Wikipedia, the free encyclopedia
Jump to: navigation, search
SEP-227,162
Clinical data
Pregnancy cat.  ?
Legal status  ?
Identifiers
ATC code None
Chemical data
Formula  ?
 YesY(what is this?)  (verify)

SEP-227,162 is an antidepressant being developed by Sepracor which is currently in clinical trials. It acts as a serotonin-norepinephrine reuptake inhibitor. As of 1st July 2009, the compound has not shown sufficient efficacy, and its future development is unknown.[1]

[edit] References

  1. ^ "SEP-225289". http://www.sepracor.com/products/sep225289.html. Retrieved 7 February 2010. [dead link]
GABAA PAMs
Others
α2δ VDCC Blockers
5-HT1A Agonists
Azapirones: Buspirone • Gepirone • Tandospirone; Others: Flesinoxan • Oxaflozane
H1 Antagonists
Diphenylmethanes: Captodiame • Hydroxyzine; Others: Brompheniramine • Chlorpheniramine • Pheniramine
CRH1 Antagonists
NK2 Antagonists
MCH1 antagonists
mGluR2/3 Agonists
mGluR5 NAMs
TSPO agonists
σ1 agonists
Others

M: PSO/PSI

dsrd (o, p, m, p, a, d, s), sysi/epon, spvo

proc(eval/thrp), drug(N5A/5B/5C/6A/6B/6D)


Stub icon This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.
Retrieved from "http://en.wikipedia.org/w/index.php?title=SEP-227,162&oldid=448231597"
Personal tools
Namespaces
Variants
Actions
Navigation
Interaction
Toolbox
Print/export
Morty Proxy This is a proxified and sanitized view of the page, visit original site.